Vaccine Hesitancy: GloboCap’s Scarlet Letter Of 2021

This non-experimental experimental vaccine is truly a historic development, because apart from saving the world from a virus that causes mild to moderate flu-like symptoms (or, more commonly, no symptoms whatsoever) in roughly 95% of those infected, and that over 99% of those infected survive, the possibilities for future applications of messenger-RNA technology, and the genetic modification of humans, generally, is virtually unlimited at this point.